News and Features


Bacterial pneumonia treatment now available; FDA deny anaphylaxis treatment; flu vaccine efficacy results; flexible dosing for Talicia; change in the therapeutic equivalence for organ rejection drug generic. 

The FDA and CDC greenlight updated COVID-19; prescription drug for dry eye disease now available; head-to-head study compares Skyrizi to Stelara for Crohn disease; the REMS program has been updated for IBS treatment Lotronex; and the FDA cracks down on companies selling unnaproved eye products.